Drug interactions for the following drug(s)
Applies to: Magnesium Sulfate 1000 MG Oral Granules <> Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet
The risk or severity of adverse effects can be increased when Magnesium Sulfate is combined with Magnesium hydroxide.
Applies to: Magnesium Sulfate 1000 MG Oral Granules <> Ciprofloxacin 500 MG Oral Tablet
The serum concentration of Ciprofloxacin can be decreased when it is combined with Magnesium Sulfate.
Applies to: Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet <> Ciprofloxacin 500 MG Oral Tablet
Aluminum hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Magnesium Sulfate 1000 MG Oral Granules <> Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet
Drug1 (rxcui = 1053346, name = Magnesium Sulfate 1000 MG Oral Granules, tty = SCD). Drug2 (rxcui = 307747, name = Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet, tty = SCD). Drug1 is resolved to MAGNESIUM SULFATE ANHYDROUS, Drug2 is resolved to Magnesium Hydroxide and interaction asserted in DrugBank between Magnesium Sulfate and Magnesium Hydroxide. Drug1 is resolved to Magnesium Sulfate, Drug2 is resolved to Magnesium Hydroxide and interaction asserted in DrugBank between Magnesium Sulfate and Magnesium Hydroxide.
Applies to: Magnesium Sulfate 1000 MG Oral Granules <> Ciprofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 1053346, name = Magnesium Sulfate 1000 MG Oral Granules, tty = SCD). Drug2 (rxcui = 309309, name = Ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to MAGNESIUM SULFATE ANHYDROUS, Drug2 is resolved to Ciprofloxacin and interaction asserted in DrugBank between Magnesium Sulfate and Ciprofloxacin. Drug1 is resolved to Magnesium Sulfate, Drug2 is resolved to Ciprofloxacin and interaction asserted in DrugBank between Magnesium Sulfate and Ciprofloxacin.
Applies to: Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet <> Ciprofloxacin 500 MG Oral Tablet
Drug1 (rxcui = 307747, name = Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG / Simethicone 25 MG Chewable Tablet, tty = SCD). Drug2 (rxcui = 309309, name = Ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to aluminum hydroxide, dried (USP), Drug2 is resolved to Ciprofloxacin and interaction asserted in DrugBank between Aluminum hydroxide and Ciprofloxacin. Drug1 is resolved to Magnesium Hydroxide, Drug2 is resolved to Ciprofloxacin and interaction asserted in DrugBank between Magnesium Hydroxide and Ciprofloxacin. Drug1 is resolved to Aluminum Hydroxide, Drug2 is resolved to Ciprofloxacin and interaction asserted in DrugBank between Aluminum hydroxide and Ciprofloxacin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.